· Receptor – ion permeability
· Receptor – second messenger
· Receptor – gene transcription
· Other: physicochemical, enzyme inhibition, voltage-gated ion channel
Pentameric |
e.g. sevoflurane at GABA-A receptor · Binds receptor beta subunit · ↑Cl- conductance through ionophore · Hyperpolarisation · ↓action potential |
Ionotropic glutamate |
e.g. ketamine at NMDA receptor · Binds PCP site · ↓Ca2+>Na+=K+ conductance · ↓ICF [Ca2+] -> ↓action potential |
Ionotropic purinergic |
e.g. ATP at P2X, P2Y · Binds receptors · ↑Na+ = K+ > Ca2+ conductance |
G protein-coupled receptor |
e.g. adrenaline agonist at β1 adrenoceptor, a Gs GPCR · Binds ECF domain · Conformational change · GTP displaces GDP; α-GTP dissociates from βγ dimer · α-GTP activates adenylyl cyclase -> ↑cAMP -> ↑activity PKA -> Phosphorylation of: o L-Ca2+: ↑Ca2+ influx on excitation o Myosin -> ↑rate of cycling o Troponin I and phospholamban-> ↑rate of relaxation
*Note G inhibitory (↓cAMP) and Gq (↑IP3, DAG), others exist |
Receptor tyrosine kinase |
e.g. insulin agonist at insulin receptor · Binds ECF α-subunits · ICF β-subunits autophosphorylate · Activation of tyrosine kinase activity · ↑PI3K activity (e.g. ↑GLUT4 expression) · ↑MAPK activity (growth) |
Transcription factor |
e.g. thyroxine at thyroid hormone receptor · Unbound receptor in cytosol · Bound receptor migrates to nucleus · ↑↓gene transcription |
Voltage-gated ion channel inhibition |
· e.g. lignocaine at VDNaC · ↓Action potential formation |
Enzyme inhibition |
· Reversible: e.g. neostigmine + AChE -> carbamylate ester · Irreversible: e.g. organophosphate + AChE -> phosphorylated ester |
Physicochemical |
· Alter pH: e.g. sodibic for GORD · Chelation: e.g. g-cyclodextrin + rocuronium · Osmosis: lactulose -> stool softening · ?Charge neutralization: heparin (negative) + protamine (positive) -> stable salt |
Structural analogy |
· e.g. azathioprine for purine |
Antibody-antigen |
· e.g. imatinib for BCR-ABL in chronic myeloid leukaemia |